Home › Funds › Southeastern Asset Management › REGN
Southeastern Asset Management position in REGN
REGENERON PHARMACEUTICALS INC. · Health Care
Latest position (Q2 2026)152.32K sh
Reported value held$94.98M
Portfolio Weight4.95%
First reportedQ1 2025
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 114.88K | $72.86M | New |
| Q2 2025 | 160.58K | $84.31M | Add |
| Q3 2025 | 144.61K | $81.31M | Reduce |
| Q4 2025 | 165.79K | $127.97M | Add |
| Q1 2026 | 130.66K | $100.95M | Reduce |
| Q2 2026 | 152.32K | $94.98M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding REGN
- Vanguard Group 9.08M sh · $7.00B · Q4 2025
- BlackRock Inc 9.11M sh · $5.68B · Q2 2026
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- Invesco Ltd 3.94M sh · $2.46B · Q2 2026
- JPMorgan Chase & Co 3.77M sh · $2.38B · Q2 2026
- Franklin Resources 2.77M sh · $1.73B · Q2 2026
- Geode Capital Management 2.63M sh · $1.63B · Q2 2026
- Morgan Stanley 1.40M sh · $871.53M · Q2 2026
- Goldman Sachs Group 1.33M sh · $831.98M · Q2 2026
- Bank of America Corp 1.29M sh · $805.02M · Q2 2026
- Wellington Management Group 1.27M sh · $791.95M · Q2 2026
- Norges Bank Investment Management 1.17M sh · $731.29M · Q2 2026